Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 15-Feb-24 5:02 PM View:  | Gault Laura Chief Medical Officer | Sage Therapeutics, Inc. (SAGE) | 13-Feb-24 | Grant | 11,250 | -- | -- | 4956% 0.23K to 11.48K | |
| 15-Feb-24 5:02 PM View: | Benecchi Christopher Chief Business Officer | Sage Therapeutics, Inc. (SAGE) | 13-Feb-24 | Grant | 13,500 | -- | -- | 228% 5.93K to 19.43K | |
| 15-Feb-24 5:02 PM View: | Iguchi Kimi CFO & Treasurer | Sage Therapeutics, Inc. (SAGE) | 13-Feb-24 | Grant | 11,250 | -- | -- | 16% 70.43K to 81.68K | |
| 15-Feb-24 5:02 PM View: | Cook Anne Marie SVP, GC & Secretary | Sage Therapeutics, Inc. (SAGE) | 13-Feb-24 | Grant | 11,250 | -- | -- | 81% 13.93K to 25.18K | |
| 04-Jan-24 4:07 PM View: | Iguchi Kimi CFO & Treasurer | Sage Therapeutics, Inc. (SAGE) | 02-Jan-24 | Option Exercise | 1,642 | $1.36 | $2,233.12 | 2% 68.79K to 70.43K | |
| 30-Nov-23 4:04 PM View: | Cook Anne Marie SVP, GC & Secretary | Sage Therapeutics, Inc. (SAGE) | 28-Nov-23 | Grant | 4,000 | -- | -- | 37% 10.89K to 14.89K | |
| 30-Nov-23 4:04 PM View: | Cook Anne Marie SVP, GC & Secretary | Sage Therapeutics, Inc. (SAGE) | 28-Nov-23 | Payment of Exercise | 1,174 | $19.27 | $22,623.00 | (8%) 14.89K to 13.72K | |
| 30-Nov-23 4:04 PM View: | Iguchi Kimi CFO & Treasurer | Sage Therapeutics, Inc. (SAGE) | 28-Nov-23 | Grant | 3,500 | -- | -- | 5% 66.23K to 69.73K | |
| 30-Nov-23 4:04 PM View: | Jonas Jeffrey M Director | Sage Therapeutics, Inc. (SAGE) | 28-Nov-23 | Grant | 10,000 | -- | -- | 8% 121.98K to 131.98K | |
| 30-Nov-23 4:04 PM View: | Iguchi Kimi CFO & Treasurer | Sage Therapeutics, Inc. (SAGE) | 28-Nov-23 | Payment of Exercise | 943 | $19.27 | $18,171.60 | (1%) 69.73K to 68.79K | |
| 30-Nov-23 4:04 PM View: | Jonas Jeffrey M Director | Sage Therapeutics, Inc. (SAGE) | 28-Nov-23 | Payment of Exercise | 3,935 | $19.27 | $75,827.50 | (3%) 131.98K to 128.05K | |
| 11-Aug-23 8:51 AM View: | Barrett Elizabeth Director | Sage Therapeutics, Inc. (SAGE) | 09-Aug-23 | Private Purchase | 2,000 | $18.64 | $37,278.60 | 200% 1.0K to 3.0K | |
| 11-May-23 8:58 AM View: | Barrett Elizabeth Director | Sage Therapeutics, Inc. (SAGE) | 09-May-23 | Purchase | 1,000 | $50.50 | $50,500.00 | 100% 0 to 1.0K | |
| 17-Mar-23 4:09 PM View: | Iguchi Kimi CFO & Treasurer | Sage Therapeutics, Inc. (SAGE) | 15-Mar-23 | Option Exercise | 3,000 | $1.36 | $4,080.00 | 5% 62.56K to 65.56K | |
| 23-Feb-23 6:03 PM View: | Iguchi Kimi CFO & Treasurer | Sage Therapeutics, Inc. (SAGE) | 23-Feb-23 | Option Exercise | 250 | $1.36 | $340.00 | < 1% 62.31K to 62.56K | |
| 23-Feb-23 6:03 PM View: | Iguchi Kimi CFO & Treasurer | Sage Therapeutics, Inc. (SAGE) | 21-Feb-23 | Option Exercise | 750 | $1.36 | $1,020.00 | 1% 61.56K to 62.31K | |
| 10-Feb-23 4:42 PM View: | Jonas Jeffrey M Director | Sage Therapeutics, Inc. (SAGE) | 10-Feb-23 | Planned Option Sale | 11,643 | $44.61 | $519,413.00 | (9%) 133.62K to 121.98K | |
| 10-Feb-23 4:42 PM View: | Jonas Jeffrey M Director | Sage Therapeutics, Inc. (SAGE) | 10-Feb-23 | Option Exercise | 11,643 | $0.45 | $5,239.35 | 10% 121.98K to 133.62K | |
| 07-Feb-23 4:10 PM View: | Benecchi Christopher Chief Business Officer | Sage Therapeutics, Inc. (SAGE) | 03-Feb-23 | Payment of Exercise | 2,119 | $44.16 | $93,575.00 | (29%) 7.38K to 5.26K | |
| 07-Feb-23 4:10 PM View: | Iguchi Kimi CFO & Treasurer | Sage Therapeutics, Inc. (SAGE) | 03-Feb-23 | Grant | 2,850 | -- | -- | 5% 59.62K to 62.47K | |
| 07-Feb-23 4:11 PM View: | Robichaud Albert Chief Scientific Officer | Sage Therapeutics, Inc. (SAGE) | 03-Feb-23 | Payment of Exercise | 1,127 | $44.16 | $49,768.30 | (< 1%) 146.68K to 145.55K | |
| 07-Feb-23 4:10 PM View: | Cook Anne Marie SVP, GC & Secretary | Sage Therapeutics, Inc. (SAGE) | 03-Feb-23 | Grant | 2,850 | -- | -- | 33% 8.63K to 11.48K | |
| 07-Feb-23 4:10 PM View: | Iguchi Kimi CFO & Treasurer | Sage Therapeutics, Inc. (SAGE) | 03-Feb-23 | Payment of Exercise | 914 | $44.16 | $40,362.20 | (1%) 62.47K to 61.56K | |
| 07-Feb-23 4:11 PM View: | Jonas Jeffrey M Director | Sage Therapeutics, Inc. (SAGE) | 03-Feb-23 | Grant | 5,100 | -- | -- | 4% 118.31K to 123.41K | |
| 07-Feb-23 4:10 PM View: | Benecchi Christopher Chief Business Officer | Sage Therapeutics, Inc. (SAGE) | 03-Feb-23 | Grant | 6,750 | -- | -- | 1073% 0.63K to 7.38K | |
| 07-Feb-23 4:10 PM View: | Cook Anne Marie SVP, GC & Secretary | Sage Therapeutics, Inc. (SAGE) | 03-Feb-23 | Payment of Exercise | 980 | $44.16 | $43,276.80 | (9%) 11.48K to 10.5K | |
| 07-Feb-23 4:11 PM View: | Jonas Jeffrey M Director | Sage Therapeutics, Inc. (SAGE) | 03-Feb-23 | Payment of Exercise | 1,427 | $44.16 | $63,016.30 | (1%) 123.41K to 121.98K | |
| 07-Feb-23 4:11 PM View: | Robichaud Albert Chief Scientific Officer | Sage Therapeutics, Inc. (SAGE) | 03-Feb-23 | Grant | 3,375 | -- | -- | 2% 143.31K to 146.68K | |
| 11-Jan-23 4:02 PM View: | Iguchi Kimi CFO & Treasurer | Sage Therapeutics, Inc. (SAGE) | 09-Jan-23 | Option Exercise | 1,600 | $1.36 | $2,176.00 | 3% 58.02K to 59.62K | |
| 05-Jan-23 4:30 PM View: | Iguchi Kimi CFO & Treasurer | Sage Therapeutics, Inc. (SAGE) | 04-Jan-23 | Option Exercise | 1,800 | $1.36 | $2,448.00 | 3% 56.22K to 58.02K | |
| 05-Jan-23 4:29 PM View: | Jonas Jeffrey M Director | Sage Therapeutics, Inc. (SAGE) | 03-Jan-23 | Option Exercise | 2,501 | $28.63 | $71,603.60 | 2% 115.81K to 118.31K | |
| 30-Nov-22 4:15 PM View: | Paul Steven M Director | Sage Therapeutics, Inc. (SAGE) | 28-Nov-22 | Acquisition (other) | 5 | $38.17 | $190.84 | < 1% 593.11K to 593.11K | |
| 15-Nov-22 4:04 PM View: | Greene Barry E President and CEO Director | Sage Therapeutics, Inc. (SAGE) | 10-Nov-22 | Private Purchase | 14,500 | $34.48 | $500,022.00 | 45% 32.44K to 46.94K | |
| 09-May-22 9:32 AM View: | Golumbeski George Director | Sage Therapeutics, Inc. (SAGE) | 05-May-22 | Private Purchase | 8,000 | $31.45 | $251,563.00 | 100% 0 to 8.0K | |
| 29-Apr-22 8:40 AM View: | Jonas Jeffrey M Director | Sage Therapeutics, Inc. (SAGE) | 27-Apr-22 | Option Exercise | 30,944 | $0.45 | $13,924.80 | 36% 84.86K to 115.81K | |
| 18-Feb-22 4:10 PM View: | Iguchi Kimi CFO & Treasurer | Sage Therapeutics, Inc. (SAGE) | 17-Feb-22 | Option Exercise | 4,500 | $1.36 | $6,120.00 | 9% 51.1K to 55.6K | |
| 18-Feb-22 4:10 PM View: | Jonas Jeffrey M Chief Innovation Officer Director | Sage Therapeutics, Inc. (SAGE) | 17-Feb-22 | Option Exercise | 4,000 | $0.45 | $1,800.00 | 5% 80.86K to 84.86K | |
| 23-Nov-21 5:15 PM View: | Iguchi Kimi CFO & Treasurer | Sage Therapeutics, Inc. (SAGE) | 23-Nov-21 | Option Exercise | 1,000 | $1.36 | $1,360.00 | 2% 50.1K to 51.1K | |
| 23-Nov-21 5:15 PM View: | Iguchi Kimi CFO & Treasurer | Sage Therapeutics, Inc. (SAGE) | 22-Nov-21 | Option Exercise | 2,500 | $1.36 | $3,400.00 | 5% 47.6K to 50.1K | |
| 12-Nov-21 4:53 PM View: | Paul Steven M Director | Sage Therapeutics, Inc. (SAGE) | 09-Nov-21 | Acquisition (other) | 1 | $43.36 | $43.36 | < 1% 514.57K to 514.57K | (2%) |
| 21-Oct-21 4:03 PM View: | Jonas Jeffrey M Chief Innovation Officer Director | Sage Therapeutics, Inc. (SAGE) | 19-Oct-21 | Payment of Exercise | 4,374 | $40.29 | $176,228.00 | (5%) 85.24K to 80.86K | |
| 21-Oct-21 4:04 PM View: | Iguchi Kimi CFO & Treasurer | Sage Therapeutics, Inc. (SAGE) | 19-Oct-21 | Grant | 3,800 | -- | -- | 8% 44.82K to 48.62K | |
| 21-Oct-21 4:04 PM View: | Iguchi Kimi CFO & Treasurer | Sage Therapeutics, Inc. (SAGE) | 19-Oct-21 | Payment of Exercise | 1,024 | $40.29 | $41,257.00 | (2%) 48.62K to 47.6K | |
| 21-Oct-21 4:03 PM View: | Cook Anne Marie SVP, GC & Secretary | Sage Therapeutics, Inc. (SAGE) | 19-Oct-21 | Grant | 3,800 | -- | -- | 73% 5.21K to 9.01K | |
| 21-Oct-21 4:03 PM View: | Cook Anne Marie SVP, GC & Secretary | Sage Therapeutics, Inc. (SAGE) | 19-Oct-21 | Payment of Exercise | 1,116 | $40.29 | $44,963.60 | (12%) 9.01K to 7.89K | |
| 21-Oct-21 4:03 PM View: | Robichaud Albert Chief Scientific Officer | Sage Therapeutics, Inc. (SAGE) | 19-Oct-21 | Grant | 3,800 | -- | -- | 3% 139.94K to 143.74K | |
| 21-Oct-21 4:03 PM View: | Robichaud Albert Chief Scientific Officer | Sage Therapeutics, Inc. (SAGE) | 19-Oct-21 | Payment of Exercise | 1,116 | $40.29 | $44,963.60 | (< 1%) 143.74K to 142.62K | |
| 21-Oct-21 4:03 PM View: | Jonas Jeffrey M Chief Innovation Officer Director | Sage Therapeutics, Inc. (SAGE) | 19-Oct-21 | Grant | 10,000 | -- | -- | 13% 75.24K to 85.24K | |
| 21-Oct-21 4:02 PM View: | Kanes Stephen Chief Medical Officer | Sage Therapeutics, Inc. (SAGE) | 19-Oct-21 | Grant | 3,800 | -- | -- | 35% 10.79K to 14.59K | |
| 21-Oct-21 4:02 PM View: | Kanes Stephen Chief Medical Officer | Sage Therapeutics, Inc. (SAGE) | 19-Oct-21 | Payment of Exercise | 1,120 | $40.29 | $45,124.80 | (8%) 14.59K to 13.47K |
